Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00291746
Status:
COMPLETED
Last Update Posted:
2009-03-12
First Post:
2006-02-14
Brief Title:
Validation of RDQ Questionnaire
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A Single-Blind Single Arm Study to Validate the Reflux Disease Questionnaire RDQ for the Diagnosis of Reflux Disease in Primary Care in Patients Treated With Esomeprazole 40 mg od
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study is to determine the accuracy of the Reflux Disease Questionnaire RDQ as a diagnostic test for gastroesophageal reflux disease Symptom evaluation by the RDQ will be compared with other established approaches to the diagnosis of gastroesophageal reflux disease GERD in a primary care patient population with symptoms thought to be of upper gastrointestinal GI tract origin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DIAMOND | None | None | None |